ARWR holders · CITADEL ADVISORS LLC 13F · ARWR stock
CITADEL ADVISORS LLC Arrowhead Pharmaceuticals Inc (ARWR) 13F holding
CITADEL ADVISORS LLC reported 187,000 ARWR shares valued at $11.72B as of 2026-03-31 (COM), Call. Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 187,000 | $11.72B | Call |
| 2026-03-31 | 98,194 | $6.16B | COM |
| 2026-03-31 | 65,300 | $4.09B | Put |
| 2025-12-31 | 474,259 | $31.49B | COM |
| 2025-12-31 | 234,100 | $15.54B | Call |
| 2025-12-31 | 66,700 | $4.43B | Put |
| 2025-09-30 | 317,614 | $10.95B | COM |
| 2025-09-30 | 125,900 | $4.34B | Call |
| 2025-09-30 | 65,000 | $2.24B | Put |
| 2025-06-30 | 187,200 | $2.96B | Put |
| 2025-06-30 | 72,300 | $1.14B | Call |
| 2025-06-30 | 62,245 | $983.5M | COM |
Not investment advice. Cached 13F row, not EDGAR XML.